Optimization of Glipizide sustained release matrix tablet formulation by central composite design- response surface methodology
|
|
- Earl Cole
- 5 years ago
- Views:
Transcription
1 Research Article Optimization of Glipizide sustained release matrix tablet formulation by central composite design- response surface methodology Parasuram Rajam Radhika* 1, Tapan kumar Pal 1, Thangavel Sivakumar 2. *1 Bioequivalence Study Centre, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India Nandha College of Pharmacy and Research Institute, Koorapalayam Pirivu, Erode, Tamilnadu, India For correspondence:parasuram Rajam Radhika,Bioequivalence Study Centre, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India radhi_kannan2005@yahoo.co.in Received on: ; Accepted on : ABSTRACT The aim of the present study was to design an oral sustained release matrix tablet of Glipizide and to optimize the drug release profile using response surface methodology. Tablets were prepared by wet granulation method using HPMC K 100 and Eudragit L 100 as matrix forming polymers. A Central composite design for 2 factors at 3 levels each was employed to systematically optimize drug release profile. HPMC K 100 and Eudragit L 100 were taken as the independent variables. The dependent variables selected were % of drug released in 2 hrs (rel 2 hrs), % of drug released in 8 hrs (rel 8 hrs), and % of drug released in 12 hrs (rel 12hrs). Contour plots were drawn and optimum formulations were selected by feasibility and grid searches. The formulated tablets exhibited Non fickian drug release kinetics approaching Zero order as the value of release rate exponent (n) varied between and0.7354, resulting in regulated and complete release until 24 hrs. The polymer HPMC K 100 and Eudragit L 100 had significant effect on the drug release from the tablets (P<0.05). Polynomial mathematical models, generated for various response variables using multiple linear regression analysis, were found to be statistically significant (P<0.05).Validation of optimization study performed using 8 confirmatory runs indicated very high degree of prognostic ability to response surface methodology, with percentage error varied between and Besides unveiling the effect of the 2 factors on the various response variables, the study helped in finding the optimum formulation with sustained drug release. Key words: Sustained Release: Matrix Tablet, Hydroxy propyl methyl cellulose (HPMC K 100), Eudragit L 100, and Central Composite Design. INTRODUCTION Sustained or controlled release delivery systems can achieve predictable and reproducible release rates, extended duration of activity for short half life drugs, decreased toxicity, and reduction of required dose, optimized therapy and better patient compliance. Matrix type sustained delivery systems are popular because of their ease of manufactures. It excludes complex production procedure such as coating and pellitization during manufacturing and drug release from the dosage form is controlled mainly by the type and proportion of the polymers used in the preparation. Hydrophilic polymer matrix is widely used for formulating a sustained release dosage form (1-4). Hydrophilic polymer matrix system are widely used for designing oral sustained release delivery systems because of their flexibility to provide a desirable drug release profile, cost effectiveness, and broad regulatory acceptance. The hydrophilic polymer selected for the present study was HPMC K HPMC K 100 forms transparent tough and flexible films from aqueous solution. The films dissolve completely in the gastrointestinal tract at any biological ph and provide good bioavailability of the active ingredient.eudragit L 100 was also used along with the HPMC K-100 to get the required sus- 94
2 tained release of the drug. Glipizide is widely used sulphonyl urea antidiabetic agent, adjunct to diet to the management of type 2 (Non insulin dependent) diabetes mellitus in patients whose hyperglycemia cannot be controlled by diet and exercise alone. Glipizide stimulates insulin secretion from the β cells of pancreatic islets tissue, increases the concentration of insulin in the pancreatic vein and may increase the number of insulin receptors (5). It is a weak acid (pka = 5.9) practically insoluble in water and acidic environment but highly permeable (class 2) according to the Biopharmaceutical Classification System (BCS) (6). The oral absorption is uniform, rapid and complete with a bioavailability of nearly 100% and an elimination half-life of 2 4 h (6). Glipizide is reported to have a short biological half-life (3.4 ± 0.7 h) requiring it to be administered in 2 to 3 doses of 2.5 to 10 mg per day (7). Sustained release formulations that would maintain plasma levels of drug for 8 to 12 hrs might be sufficient for once a day dosing for Glipizide. SR products are needed for Glipizide to prolong its duration of action and to improve patient compliance. In development of a sustain release tablet dosage form, an important issue is to design an optimized formulation with an appropriate dissolution rate in a short time period and minimum number of trials. For this purpose, a computer based optimization technique with a response surface methodology (RSM) is widely practiced in the development and optimization of drug delivery devices. Based on the principal of design of experiments, the methodology encompasses the use of various types of experimental designs, generation of polynomial equations, and mapping of the response over the experimental domain to determine the optimum formulations. The technique requires minimum experimentation and time, thus proving to be far more effective and cost effective than the conventional methods of formulating dosage forms. The current study aims at developing and optimizing a sustained release matrix tablet of Glipizide using HPMC K-100 and Eudragit L 100 by wet granulation method and optimizes the formulation using RSM. Use of the response surface methodology has been proved to be a useful tool in the development and optimization (8). Different steps involved in response surface methodology include experimental design, regression analysis, constraint optimization and validation. MATERIALS AND METHODS MATERIALS: Glipizide, HPMC K-100, Eudragit L-100, were received as Gift sample from Aravind Remedies (AR), Chennai. Graph. Lactose, Povidone, Iso Propyl Alcohol (IPA), Aerosil, Magnesium Stearate, was of AR Grade. METHODS: Preparation of Sustained Release Matrix Tablets Table1enlists the composition of different sustain release formulations prepared using varying amounts of the polymers (HPMC K 100 and Eudragit l 100) and granulated using Povidone in Iso- propyl alcohol along with the fixed quantity of magnesium stearate as the lubricant. Drug and the excipient were homogeneously blended and subsequently compressed using double punch tabletting machine, equipped with beveled flat punch 8/32 mm, diameter (Cad mach Machinery Co: Ahemedabad, India) Experimental Design: A central composite design (CCD) with a= 1 was employed as per the standard protocol(10, 11).The amounts of HPMC K 100 ( ) and Eudragit L 100 ( ) were selected as the factors, studied at 3 levels each. The central point (0, 0) was studied in quintuplicate. All ot6her formulation and processing variables were kept invariant throughout the study. Table 2 summarizes an account of the 13 experimental runs studied, their factor combination and the translation of the coded levels to the experiment units employed during the study. % of drug released in 2hrs ( rel 2 hrs ) ( Y 1 ), % of drug released in 8 hrs ( rel 8hrs ) ( Y 2 ), % of drug released in 12 hrs ( rel 12 hrs ) ( Y 3 ) were taken as the response variables. Tablet assay and Physical Examination 10 tablets were taken and the drug was extracted using methanol and the samples were analyzed spectrophotometrically (Shimadzu Model 1601) at 276 nm. Tablets were also evaluated for hardness (n=10), Friability (n=10), Weight Variation (n=10) and thickness (n=10). Invitro Drug Release Studies Dissolution studies were performed for all the formulation combinations, in triplicate, determined using USP 22 type I dissolution apparatus ( Electro lab, TDT- 08 L ) where 900 ml of 0.1 N HCl and phosphate buffer of ph 6.8 were used as dissolution media maintained at 37 o C ( ± 0.5 o c ) at 50 rpm. The release rates from the tablets were conducted in the dissolution medium of 0.1 N HCL for 2 hours and thereafter in phosphate buffer of ph ml of aliquot were withdrawn at 2, 4, 8, and 12 hours with replacement of fresh media. Solution samples were analyzed by using UV- Spectrophotometer (Shimadzu Model 16010) at 276 nm. Drug release profiles were drawn using MS-Excel Software and the values were obtained by interpolation from Excel 95
3 Table 1 Composition of 10 mg Glipizide Sustained Release Matrix Tablets Ingredients Amount (mg) Glipizide 10 HPMC K Eudragit L Povidone 10 Aerosil 1 Iso Propyl Alcohol 100 Magnesium Stearate 2 Lactose q.s to 173 mg Table 2 Factor combination as per the chosen experimental design Trial No: Coded factor levels. I II III IV V VI VII VIII IX X XI XII XIII Translation of coded levels in actual units Coded level HPMC K 100 (mg) Eudragit L 100 (mg) Table 3: Drug Release Parameters of Various Trial Formulations Prepared as per the Experimental Design Trial No Factor amount (mg) rel 2hrs(%) rel 8hrs(%) rel 12hrs (%) n r =HPMC K100, = Eudragit L 100, rel 2 hrs = Release in 2 hours, rel 8 hrs =Release in 8 hrs, rel 12 hrs = Release in 12 hrs, n= Release component obtained from Koresmeyer Equation, r 2 = regression coefficient. 96
4 Table 4: Analysis of variance (ANOVA) for all three Responses rel 2hrs (Y 1 ) rel 8 hrs (Y 2 ) rel 12 hrs (Y 3 ) Source F p-value F p-value F p- value Model A < B AB < A < <01 B A 2 B AB < Significant effect (p value < 0.5) of factors on individual responses is shown in bold, rel 2hrs: Release in 2 hrs, rel 8hrs: Release in 8 hrs, rel 12 hrs: Release in 12 hrs, A- HPMC K 100, B- Eudragit L 100. Table 5:Composition of the Checkpoint Formulations, the Predicted and Experimental Values of Response Variables, and Percentage Prediction Error S. No Composition HPMCK100 : Eudragit L100 60:50 60:70 50:50 50 : 60 70:50 50:70 60:60 70:70 Response Variable Experimental value Predicted value Residual Rel 2 hrs Rel 8 hrs Rel 12 hrs
5 Cumulative Percentage Release Time in Hours 60:60 55:55 65:55 65:65 55: : : : : :49.20 Fig 1 Cumulative Glipizide Release (%) verses Time profiles for glipizide matrix formulation prepared as per the experimental design. Each value represents the mean ±S.D, n= 13 Rel 2 hrs Design Points Rel 2 hrs Rel 2 hrs Design points above predicted value Design points below predicted value X2 = X2 = Rel 2 hrs Fig- 2 Response surface plot and corresponding contour plot showing the relationship between various levels of polymer AA (HPMC K 15) and BB (Eudragit L 100) on drug release in 2 Hrs 98
6 Rel 8 hrs Design Points Rel 8 hrs Rel 8 hrs Design points above predicted value Design points below predicted value X2 = X2 = Rel 8 hrs Figure 3. Response surface plot and corresponding contour plot showing the relationship between various levels of polymer AA (HPMC K 15) and BB (Eudragit L 100) on drug release in 8 Hrs Rel 12 hrs Design Points X2 = - Rel 12 hrs Rel 12 hrs Design points above predicted value Design points below predicted value X2 = Rel 12 hrs Fig 4: Response surface plot and corresponding contour plot showing the relationship between various levels of polymer AA (HPMC K 15) and BB (Eudragit L 100) on drug release in 12 Hrs. 99
7 (A) (B) 2 hr 2 hr predicted value experimental value Residual value Experimental value (C) (D) 8 hr 8 hr Predicted released in 8 hrs (%) Experimental release in 8 hrs (%) Residual value Experimental value (E) (F) 12 hr 12 hr experimental value Residual value Experimental value Fig 5. Linear Correlation Plots (A, C, E) between Experimental and Predicted Values and the Corresponding Residual Plots (B, D, F) for various variables. Drug Release Kinetics In order to investigate the model of release from tablets, the drug release data of the formulation was analyzed with the following models, Q = K o t ( Zero Order kinetics ), ln (100 q ) = ln Q o K t ( first order kinetics ), Q= K t ( Higuchi Model ) and Koresmeyer etal s equation(12) Log ( Mt/ M& ) = log K + nlog t. where Mt is the amount of the drug release at time t, M& is the amount of drug release after infinite time, K is a release rate constant and n is the diffusion exponent indications of the drug release mechanism. Optimum Release Profile Optimum release profile for once daily SR formulation was calculated by the following equation (13) using available pharmacokinetic data (14) Dt= Dose ( t/t 1/2 where Dt = Total dose of drug Dose= Dose of the immediate release 100
8 part t= Time during which the sustained release is desired (24 hrs) t 1/2 = Half life of the drug ( 3hrs) The optimum formulation was selected on the above equation so that it could attain complete and controlled drug release upon trading off various response variables; the following maximizing criteria were adopted. rel 2hrs =14.74 rel 8hrs =52.24 rel 12 hrs =82.24 Optimization of Data Analysis and validation of optimization Model Various RSM computations for the current optimization study were performed employing Design Expert Software (Design Expert Version 7.1.3, Stat- Ease Inc, and Minneapolis, MN). Polynomial models including interaction and quadratic terms were generated for all the response variables using multiple linear regression analysis (MLRA) approach. The general form of the MLRA model is represented as the following equation: 2 2 Y= B o + B 1 + B 2 +B 3 + B 4 + B 5 + B B 7 Where B 0 is the intercept representing the arithmetic average of all quantitative outcomes of 13 runs. B 1 to B 7 are the coefficients computed from the observed experimental response values of Y: and & are the coded levels of the independent variables. The terms and 2 (i = 1to 2) represent the interaction and quadratic terms respectively. Statistical validity of the polynomials was established on the basis of ANOVA provision in the Design Expert Software. Subsequently, the feasibility and grid searches were performed to locate the composition of optimum formulations (15). Two dimensional (2D) contour plots were constructed based on the model polynomial functions using Design Expert Software. These plots are very useful to see interactions effects on the factors on the responses. Eight optimum checkpoints were selected based on the criteria from optimum formulation described earlier by intensive grid search, performed over the entire experimental domain, to validate the chosen experimental design and polynomial equations. The formulations corresponding to these checkpoints were prepared and evaluated for various response properties. Subsequently, the resultant experimental data of response properties were quantitatively compared with that of their predicted values. Also, linear regression plots between observed and predicted values of the response properties of the Eudragit L 100 and HPMC K 100. were drawn using MS-Excel, forcing the line through origin. RESULTS AND DISCUSSION Drug content and Physical Evaluation The assayed content of drug in various formulations varied between 98.3 ± 0.43 to 99.5 ± 0.3 (mean 98.9 %). Tablet weight varied between ± to 0.251± mg, Thickness between 2.45 to 2.59 mm, Hardness between Kg/ cm2, and friability ranged between percent. Thus all the physical parameters of the matrices were practically within control. In-Vitro drug release studies The In-Vitro dissolution studies ere performed using USP-22 type I dissolution apparatus at 50 rpm and analyzed by UV- visible spectrophotometer. In the current study, the values of release rate exponent (n), calculated as per the Koresmeyer model ranged between and and Zero order release were found to be and (Table - 3) For matrix tablets n value of near 0.5 indicates diffusion control and n value of near 1.0 indicates erosion or relaxation control. Intermediate values suggest that diffusion and erosion contribute to the overall release mechanism. In our experiment the results of n clearly indicated that the diffusion and erosion are the dominant mechanism of drug release from these formulations. Diffusion is related to transport of drug from the dosage matrix into the Invitro study fluid depending on the concentration of the hydrophilic polymer. As gradient varies, the drug is released, and the distance for diffusion increases. This could explain why the drug diffuses at a comparatively slower rate as the distance for diffusion increases. Total amount of Glipizide released from all the formulations up to 8 hrs ranged between 55.24% and % indicating in complete drug release at higher concentration of Eudragit L 100 as well as HPMC K 100. Rate of drug release tended to decrease with increase in the content of either Eudragit L 1000 or HPMC K 100. Thereby the viscosity of the gel layer around the tablet increases with increase in the hydro gel concentration, thus limiting the release of active ingredient (16, 17). The gel formed during the penetration of dissolution media into the matrix structure; consist of closely packed swollen particles. With further increase in polymer amount, thicker gel forms inhibiting dissolution media penetration more strongly, resulting in significant reduction in the values of rel 8 hr indicates slower drug release. The values of rel 8hrs enhanced markedly from % and rel 12 hrs from , observed at high levels of both the variables. This indicated considerable release retarding potential 101
9 rel 12 hrs.figure 2 exhibits that rel 2 hrs vary in a non linear to circular fashion, but in a descending pattern with an increase in the amount of HPMC K 15 and Eudragit L 100. In contrast to the results of drug release in 2 hr contour plot for drug release in 8 hrs (Fig 3) reveal that rel 8 hrs varies in somewhat linear with increase in polymers. Fig 4 exhibits an inverted curve, but in an ascending pattern with an increase in the amount of HPMC K 15 and Eudragit L 100. Fig 5 shows the Linear Correlation Plots (A, C, E) between Experimental and Predicted Values and the Corresponding Residual Plots (B, D, F) for various variables. Validation of RSM Results For all of the 8 check point formulations, the results of the physical evaluation and tablet assay were found to be within limits. Table 5 lists the composition of the check points, their predicted and experimental values of all the response variables, and the percentage error in prognosis. Upon comparison of the observed responses with that of the anticipated responses, the prediction error varied between and CONCLUSION Controlled drug release following Koresmeyer Model attained in the current study indicates that the hydrophobic matrix tablet of Glipizide, prepared using HPMC K 15 and Eudragit L 100, can successfully be employed as once a day oral controlled release drug delivery system. Both the polymers play an important role for the sustained release of Glipizide. However, appropriate balancing between various levels of the polymers HPMC K 15 and Eudragit L 100may contribute better results. High degree of prognosis obtained using RSM signifies that a 2 factor CCD is quite efficient in optimizing drug delivery systems. REFERANCES 1. Vidyadhara S, Rao P.R, Prasad J.A, Indian J Pharm Sci; (2004): 66, Reddy K.R, Mutalik. AAPS Pharm Sci Tech; (2003):4, Mohammed A.D, James L.F,Micheal H.R, John E.H, Raabi- Siahboomi A.R, Pharm Dev Tech ; (1999): 4, Lee B.J, Ryu S.G, Cui J.H, Drug Dev Ind Pharm, 25, (1999) 5. R.K.Varma and S.Garg. Developmental and Evaluation of Osmotic ally controlled oral drug delivery system of Glipizide, Eur J.Pharm.Biopharm57 (2004) S. Jamzad and R. Fassihi, Development of Controlled Release Low Dose Class II drug Glipizide Int. J.Pharm,312 (2006) Martindale, The complete drug Referance (ed S.C. Sweetman), 34 th ed, Pharmaceutical Press, London 2005, pp J.K. Patel, R.P Patel, A.F Amin and M.M Patel, Formulation and Evaluation of Glipizide. 9. K.P.R. Chowdrary and Y.S Rao, Design and Invitro and In vivo Evaluation of Mucoadhesive microcapsules of Glipizide for oral controlled release, AAPS, Pharm sci, Tech 4 (2003). 10. Singh,B, Kumar R, Ahuja N, Crit Rev Ther Drug Carrier Syst 22, (2005). 11. Singh B, Mehta G, Kumar R, Bhatia A, Ahuja N, Katare O.P, Curr, Drug Deliv,2, (2005). 12. Koresmeyer R W, Gurny R, Doelker E.M Buri P, Peppas N A, Int J Pharm, 15,25 (1983). 13. Rawlins EA Bentleys TextBook of Pharmaceutics, Cassell and Collier Macmillian London, Defang O, Shufang N, Wei L, Drug Dev Ind Pharm, 2005, 31,( ). 15. Singh B, Ahuja N, Drug Dev Ind Pharm., 28, , Ford JL, Rubinstein MH, Hogan JE, Formulation of Sustained Release Promethazine Hydrocholide Tablets using HPMC matrices Int. J.Pharm 1985,24,327-33/ Vazques MJ, Perez- Marcos B, Gomez Amoza JL, Martmez- Pachero R, Souto C, Concheiro A. Influence of technological variables on release of drugs from hydrophilic matrices Drug. Dev.Ind. Pharm, 1992:18, Source of support: Nandha College of Pharmacy, Erode -52, Tamilnadu., Conflict of interest: None Declared 102
Volume: 2: Issue-3: July-Sept ISSN FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF NICORANDIL
Volume: 2: Issue-3: July-Sept -2011 ISSN 0976-4550 FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF NICORANDIL Ajaykumar Patil*, Ashish Pohane, Ramya Darbar, Sharanya Koutika, Alekhya
More informationJournal of Chemical and Pharmaceutical Research
Available on line www.jocpr.com Journal of Chemical and Pharmaceutical Research ISSN No: 0975-7384 CODEN(USA): JCPRC5 J. Chem. Pharm. Res., 2011, 3(3):159-164 Studies on formulation and in vitro evaluation
More informationA Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac
Asian Journal of Chemistry Vol. 22, No. 6 (2010), 4239-4244 A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac K.P.R. CHOWDARY*
More informationDEVELOPMENT AND IN VITRO EVALUATION OF SUSTAINED RELEASE FLOATING MATRIX TABLETS OF METFORMIN HYDROCHLORIDE
ISSN: 0975-8232 IJPSR (2010), Vol. 1, Issue 8 (Research article) Received 11 April, 2010; received in revised form 17 June, 2010; accepted 13 July, 2010 DEVELOPMENT AND IN VITRO EVALUATION OF SUSTAINED
More informationSTUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS
Int. J. Chem. Sci.: 10(4), 2012, 1934-1942 ISSN 0972-768X www.sadgurupublications.com STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS K. VENUGOPAL * and K. P. R. CHOWDARY a Nirmala College
More informationMaisammaguda, Dulapally, Secundrabad.
121 P a g e International Standard Serial Number (ISSN): 2319-8141 International Journal of Universal Pharmacy and Bio Sciences 3(6): November-December 2014 INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY
More informationFORMULATION AND DEVELOPMENT OF ER METOPROLAOL SUCCINATE TABLETS
International Journal of PharmTech Research CODEN( USA): IJPRIF ISSN : 0974-4304 Vol.1, No.3, pp 634-638, July-Sept 2009 FORMULATION AND DEVELOPMENT OF ER METOPROLAOL SUCCINATE TABLETS K. Reeta Vijaya
More informationAvailable Online through Research Article
ISSN: 0975-766X Available Online through Research Article www.ijptonline.com DESIGN AND EVALUATION OF GASTRORETENTIVE TABLETS FOR CONTROLLED DELIVERY OF NORFLOXOCIN Ganesh Kumar Gudas*, Subal Debnath,
More informationDESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN
Int. J. Chem. Sci.: 10(4), 2012, 2199-2208 ISSN 0972-768X www.sadgurupublications.com DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN K. V. R. N. S. RAMESH *, B. HEMA KIRNAMAYI
More informationSTABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS
Int. J. Chem. Sci.: 8(1), 2010, 405-414 STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS V. L. NARASAIAH, T. KARTHIK KUMAR, D. SRINIVAS, K. SOWMYA, P. L. PRAVALLIKA and Sk. Md. MOBEEN
More informationJournal of Global Trends in Pharmaceutical Sciences Vol.2, Issue 4, pp , Oct -Dec 2011
ISSN: 223-7346 Research Article Journal of Global Trends in Pharmaceutical Sciences Vol.2, Issue 4, pp -394-43, Oct -Dec 211 FORMULATION AND INVITRO EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF GLIMEPIRIDE
More informationThe Relevance of USP Methodology in the Development of a Verapamil Hydrochloride (240 mg) Extended Release Formulation
METHOCEL Premium Cellulose Ethers Application Data The Relevance of USP Methodology in the Development of a Verapamil Hydrochloride (240 mg) Extended Release Formulation INTRODUCTION Hydrophilic matrices
More informationPatel Krunal M et al. IRJP 2 (2)
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN 223 87 Available online http://www.irjponline.com Research Article DESIGN DEVELOPMENT AND EVALUATION OF MODIFIED RELEASE TABLET OF MONTELUKAST SODIUM BY
More informationJournal of Global Trends in Pharmaceutical Sciences. Journal home page:
ISSN: 2230-7346 G Sridhar Babu et al. / JGTPS/ 5(4)-(2014) 2085-2092 (Research Article) Journal of Global Trends in Pharmaceutical Sciences Journal home page: www.jgtps.com FORMULATION AND IN-VITRO CHARACTERIZATION
More informationThe objective of the present investigation is to design and evaluate controlled release tablets of carvedilol, employing
Research Article Preparation and evaluation of controlled release tablets of carvedilol M L Varahala Setti, J Vijaya Ratna Division of Pharmaceutical Technology, University College of Pharmaceutical Sciences,
More informationFORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES
Int. J. Chem. Sci.: 10(1), 2012, 297-305 ISSN 0972-768X www.sadgurupublications.com FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES K. P.
More informationFORMULATION AND EVALUATION OF ACECLOFENAC SODIUM BILAYER SUSTAINED RELEASE TABLETS
International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol.1, No.4, pp 1381-1385, Oct-Dec 2009 FORMULATION AND EVALUATION OF ACECLOFENAC SODIUM BILAYER SUSTAINED RELEASE TABLETS
More informationFormulation and Development of Sustained Release Tablets of Valsartan Sodium
INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY Research Article Formulation and Development of Sustained Release Tablets of Valsartan Sodium G. Sandeep * and A. Navya Department of
More informationFormulation and evaluation of sustained release atenolol
9 Formulation, optimization and evaluation of sustained release layer of atenolol Atenolol is a cardioselective β-blocker widely prescribed for asymptomatic condition such as hypertension. It is poorly
More informationAsian Journal of Research in Biological and Pharmaceutical Sciences
Research Article ISSN: 2349 4492 Asian Journal of Research in Biological and Pharmaceutical Sciences Journal home page: www.ajrbps.com APPLICATION OF FACTORIAL DESIGN AND OPTIMIZATION OF GLIMEPIRIDE SUSTAINED
More informationAsian Journal of Pharmacy and Life Science ISSN Vol. 2 (2), July-Sept,2012
STUDIES ON EFFECT OF SUPERDISINTEGRANTS ON ETORICOXIB TABLET FORMULATIONS Chowdary K. P. R 1, Venugopal. K *2 1 College of Pharmaceutical Sciences, Andhra University, Vishakapattanam. 2 * Nirmala college
More informationJournal of Chemical and Pharmaceutical Research
Available on line www.jocpr.com Journal of Chemical and Pharmaceutical Research ISSN No: 975-7384 CODEN(USA): JCPRC5 J. Chem. Pharm. Res., 211, 3(2):786-791 Development and optimization of colon targeted
More informationDesign and In-vitro Evaluation of Silymarin Bilayer Tablets
CODEN (USA)-IJPRUR, e-issn: 2348-6465 International Journal of Pharma Research and Health Sciences Available online at www.pharmahealthsciences.net Original Article Design and In-vitro Evaluation of Silymarin
More informationVenkateswara Rao et.al Indian Journal of Research in Pharmacy and Biotechnology ISSN: (Print) ISSN: (Online)
Design and development of Metformin hydrochloride Tried sustained release tablets Venkateswara Rao T 1 *, Bhadramma N 1, Raghukiran CVS 2 and Madubabu K 3 Bapatla College of Pharmacy, Bapatla, Guntur-522101
More informationFORMULATION AND EVALUATION OF BILAYERED TABLET OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE HYDROCHLORIDE
Academic Sciences International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 975-1491 Vol 4, Suppl 5, 212 FORMULATION AND EVALUATION OF BILAYERED TABLET OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE
More informationSivakasi , Tamil Nadu, India. ABSTRACT KEYWORDS:
276 P a g e International Standard Serial Number (ISSN): 2319-8141 International Journal of Universal Pharmacy and Bio Sciences 4(1): January-February 2015 INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY AND
More informationFORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD
Int. J. Chem. Sci.: 6(3), 2008, 1270-1275 FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD K. P. R. CHOWDARY, P. TRIPURA SUNDARI and K. SURYA
More informationFormulation development of Glipizide matrix tablet using different proportion of natural and semi synthetic polymers
Pharm Methods, 2017; 8(1): 45-53 A multifaceted peer reviewed journal in the field of Pharm Analysis and Pharmaceutics www.phmethods.net www.journalonweb.com/phm Research Article Formulation development
More informationFormulation and Optimization of Immediate Release Tablet of Sitagliptin Phosphate using Response Surface Methodology
Formulation and Optimization of Immediate Release Tablet of Sitagliptin Phosphate using Response Surface Methodology Sunita Shakya Department of Pharmacy, Kathmandu University, Kavre, Nepal. Email: sunita95@gmail.com
More informationFABRICATION AND EVALUATION OF GLIMEPIRIDE CORDIA DICHOTOMA G.FORST FRUIT MUCILAGE SUSTAINED RELEASE MATRIX TABLETS
Int. J. Chem. Sci.: 7(4), 2009, 2555-2560 FABRICATION AND EVALUATION OF GLIMEPIRIDE CORDIA DICHOTOMA G.FORST FRUIT MUCILAGE SUSTAINED RELEASE MATRIX TABLETS HINDUSTAN ABDUL AHAD *, B. PRADEEP KUMAR, C.
More informationPharmaceutical Studies on Formulation and Evaluation of Sustained Release Tablets Containing Certain Drugs
Mansoura University Faculty of Pharmacy Department of Pharmaceutics Pharmaceutical Studies on Formulation and Evaluation of Sustained Release Tablets Containing Certain Drugs Thesis presented by Ali Saeed
More informationPreparation and Evaluation of Silymarin Controlled Release Tablets Prepared Using Natural Gums
1368 International Journal of Pharmaceutical Sciences and Nanotechnology Volume 4 Issue 1 April-June 211 Research Paper International Journal of Pharmaceutical Sciences and Nanotechnology Volume 4 Issue
More informationFormulation and evaluation of sustained release matrix tablet of metoprolol succinate
17; 3(5): 448-453 ISSN Print: 2394-7500 ISSN Online: 2394-5869 Impact Factor: 5.2 IJAR 17; 3(5): 445-453 www.allresearchjournal.com Received: 15-03-17 Accepted: -04-17 Mangesh R Bhalekar Ashwini R Madgulkar
More informationFormulation and Evaluation of Bilayer Tablet by Wet Granulation
ABSTRACT: Formulation and Evaluation of Bilayer Tablet by Wet Granulation Nishith Patel 1, Kanu R Patel 2, Rakesh kumar Jat 3 1 Research Scholar, JJT University, Jhunjhunu, Rajasthan, India 2 Asso. Professor,
More informationOptimization of Valsartan SR Floating Tablet Formulation by 2 2 Factorial Design and Multiple Regression Technique
Optimization of Valsartan SR Floating Tablet by 2 2 Factorial Design and Multiple Regression Technique K. Srinivasa Reddy 1, Surya Kanta Swain 2, K. P. R. Chowdary *3, S. V. U. M. Prasad 4 1 School of
More informationScholars Research Library. Formulation and evaluation of buccoadhesive tablet of Atenolol
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2011, 3(2): 34-38 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationFORMULATION AND EVALUATION OF BILAYERED TABLET OF METFORMIN HYDROCHLORIDE AND GLIMEPIRIDE
Research Article Ghanshyam Patel,, 2012; Volume 1(6): 75-87 ISSN: 2277-8713 FORMULATION AND EVALUATION OF BILAYERED TABLET OF METFORMIN HYDROCHLORIDE AND GLIMEPIRIDE -QR CODE GHANSHYAM PATEL 1, Dr. RAGIN
More informationFORMULATION AND EVALUATION OF ETORICOXIB TABLETS EMPLOYING CYCLODEXTRIN- POLOXAMER PVPK30 INCLUSION COMPLEXES
Volume: 2: Issue-4: Oct - Dec -2011 ISSN 0976-4550 FORMULATION AND EVALUATION OF ETORICOXIB TABLETS EMPLOYING CYCLODEXTRIN- POLOXAMER 407 - PVPK30 INCLUSION COMPLEXES K.P.R. Chowdary*, K. Surya Prakasa
More informationFormulation and Evaluation of Bilayer Tablets of Glimepiride and Metformin HCL
IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) e-issn: 2278-38, p-issn:2319-7676. Volume 9, Issue 1 Ver. IV (Jan. 214), PP 38-45 Formulation and Evaluation of Bilayer Tablets of Glimepiride
More informationReddy Sunil, Panakanti Pavan kumar, Kandagatla Rajanarayana and Yamsani Madhusudan Rao*
International Journal of Pharmaceutical Sciences and Nanotechnology Volume 3 Issue 1 April June 2010 Research Paper Formulation and Release Characteristic of a Bilayer Matrix Tablet Containing Glimepride
More informationChemate and Chowdary, IJPSR, 2012; Vol. 3(7): ISSN:
IJPSR (2012), Vol. 3, Issue 07 (Research Article) Received on 18 March, 2012; received in revised form 25 April, 2012; accepted 22 June, 2012 A FACTORIAL STUDY ON ENHANCEMENT OF SOLUBILITY AND DISSOLUTION
More informationOptimization of valsartan tablet formulation by 2 3 factorial design
Research Article ISSN: 0974-6943 K. P. R. Chowdary et al. / Journal of Pharmacy Research 2014,8(9, Available online through http://jprsolutions.info Optimization of valsartan tablet formulation by 2 3
More informationInternational Journal of Innovative Pharmaceutical Sciences and Research
International Journal of Innovative Pharmaceutical Sciences and Research www.ijipsr.com FORMULATION AND EVALUATION OF ph INDEPENDENT TABLETS OF ATENOLOL 1 S. Mahaboob Basha*, 2 N. Srinivas Department of
More informationPreparation and Evaluation of Ethylene Vinyl Acetate Copolymer Coated Microcapsules of Glipizide for Controlled Release
Asian Journal of Chemistry Vol. 21, No. 8 (2009), 5838-5842 Preparation and Evaluation of Ethylene Vinyl Acetate Copolymer Coated Microcapsules of Glipizide for Controlled Release K.P.R. CHOWDARY* and
More informationPreparation and Evaluation of Gastro Retentive Floating Tablets of Atorvastatin Calcium
Preparation and Evaluation of Gastro Retentive Floating Tablets of Atorvastatin Calcium Florida Sharmin 1, Md. Abdullah Al Masum 1, S. M. Ashraful Islam 1 and Md. Selim Reza 2 1 Department of Pharmacy,
More informationFORMULATION AND CHARACTERIZATION OF TELMISATAN SOLID DISPERSIONS
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 974-434 Vol.2, No.1, pp 341-347, Jan-Mar 1 FORMULATION AND CHARACTERIZATION OF TELMISATAN SOLID DISPERSIONS Kothawade S. N. 1 *, Kadam
More informationFORMULATION AND EVALUATION OF THEOPHYLLINE BILAYERED TABLETS USING HPC AS MATRIX MATERIAL
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article FORMULATION AND EVALUATION OF THEOPHYLLINE BILAYERED TABLETS USING HPC AS MATRIX MATERIAL
More informationInternational Journal of Medicine and Pharmaceutical Research
International Journal of Medicine and Pharmaceutical Research Journal Home Page: www.pharmaresearchlibrary.com/ijmpr Research Article Open Access Formulation and Evaluation of Gastroretentive Floating
More informationDESIGN, DEVELOPMENT AND OPTIMIZATION OF FAST DISSOLVING TABLET OF NEBIVOLOL HCL
DESIGN, DEVELOPMENT AND OPTIMIZATION OF FAST DISSOLVING TABLET OF NEBIVOLOL HCL Isha Shah, Alpesh Yadav, Shailendra Bhatt Maharishi Arvind Institute of Pharmacy, Mansarovar, Jaipur, India-3000. Abstract
More informationVolume: I: Issue-3: Nov-Dec ISSN
Volume: I: Issue-3: Nov-Dec -2010 ISSN 0976-4550 DESIGN AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF GLIMEPIRIDE BASED ON COMBINATION OF NATURAL AND SYNTHETIC POLYMERS Hindustan Abdul Ahad 1,
More informationBahadur S. et al /J. Pharm. Sci. & Res. Vol.1(4), 2009,
Abstract: In the present work, we developed an effective mucoadhesive tablets of omeprazole(diomeprazole magnesium powder and omeprazole pellets) by direct punch method with excellent mucoadhesive force
More informationFACTORIAL STUDIES ON THE EFFECTS OF HYDROXY PROPYL β- CYCLODEXTRIN AND POLOXAMER 407 ON THE SOLUBILITY AND DISSOLUTION RATE OF BCS CLASS II DRUGS
JChrDD Vol 2 Issue 2 2011: 89-93 ISSN 2249-6785 Journal of Chronotherapy and Drug Delivery Received: August 06, 2011 Accepted: Sep 12, 2011 Original Research Paper FACTORIAL STUDIES ON THE EFFECTS OF HYDROXY
More informationDesign and Characterization of Valsartan Loaded Press Coated Pulsatile Tablets
Research Reviews: Pharmacy & Pharmaceutical Sciences e-issn: 2320-1215 www.rroij.com Design and Characterization of Valsartan Loaded Press Coated Pulsatile Tablets Sowjanya Battu*, Madhavi K, Bhikshapathi
More informationOPTIMIZATION OF CONTROLLED RELEASE GASTRORETENTIVE BUOYANT TABLET WITH XANTHAN GUM AND POLYOX WSR 1105
Digest Journal of Nanomaterials and Biostructures Vol. 9, No. 3, July September 2014, p. 1077-1084 OPTIMIZATION OF CONTROLLED RELEASE GASTRORETENTIVE BUOYANT TABLET WITH XANTHAN GUM AND POLYOX WSR 1105
More informationEffect of Polymer Concentration and Viscosity Grade on Atenolol Release from Gastric Floating Drug Delivery Systems
Effect of Polymer Concentration and Viscosity Grade on Atenolol Release from Gastric Floating Drug Delivery Systems 1 1 1 2 U.V. Bhosale*, V. Kusum Devi, Nimisha Jain and P.V. Swamy 1 Al-Ameen College
More informationFORMULATION RELEASE STUDY OF SOME IMPORTANT DRUGS FROM SUPPOSITORY
FORMULATION RELEASE STUDY OF SOME IMPORTANT DRUGS FROM SUPPOSITORY Mohammed Younus Ali*, Sadat Ali JJT University, Churu-Bisau Road, Jhunjhunu Rajasthan ABSTRACT: The purpose of this study was to formulate
More informationA FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS
Research Article A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS K. P. R. Chowdary *, Tanniru Adinarayana, T. Vijay, Mercy. R. Prabhakhar
More informationResearch Journal of Pharmaceutical, Biological and Chemical Sciences
Research Journal of Pharmaceutical, Biological and Chemical Sciences Formulation And Invitro Evaluation Of Sustained Release Matrix Tablets Of Ibuprofen S Shanmugam, T Vetrichelvan and P Niranjan* Adhiparasakthi
More informationScholars Research Library. Formulation Development of Pioglitazone Tablets Employing β Cyclodextrin- Poloxamer 407- PVP K30: A Factorial Study
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2011, 3 (6):24-30 (http:scholarsresearchlibrary.comarchive.html) ISSN 0974-248X USA CODEN: DPLEB4 Formulation
More informationEVALUATION OF EFFERVESCENT FLOATING TABLETS. 6.7 Mathematical model fitting of obtained drug release data
EVALUATION OF EFFERVESCENT FLOATING TABLETS 6.1 Technological characteristics of floating tablets 6.2 Fourier transform infrared spectroscopy (FT-IR) 6.3 Differential scanning calorimetry (DSC) 6.4 In
More informationPreparation and Evaluation of Ethyl Cellulose Coated Microcapsules of Carbamazepine for Controlled Release
Asian Journal of Chemistry Vol. 20, No. 8 (2008), 5901-5907 Preparation and Evaluation of Ethyl Cellulose Coated Microcapsules of Carbamazepine for Controlled Release K.P.R. CHOWDARY* and MALLURU SUBBA
More informationInt. Res J Pharm. App Sci., 2013; 3(6):42-46 ISSN:
International Research Journal of Pharmaceutical and Applied Sciences (IRJPAS) Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2013; 3(6):42-46 Research Article ENHANCEMENT OF SOLUBILITY
More informationENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE
PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES ENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE Kantilal B. Narkhede *1, R. B. Laware 2, Y. P.
More informationFORMULATION AND EVALUATION OF DILTIAZEM HYDROCHLORIDE COLON TARGETED TABLETS
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article FORMULATION AND EVALUATION OF DILTIAZEM HYDROCHLORIDE COLON TARGETED TABLETS G. Subba Rao
More informationEFFECT OF PVP ON CYCLODEXTRIN COMPLEXATION OF EFAVIRENZ FOR ENHANCING ITS SOLUBILITY AND DISSOLUTION RATE
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article EFFECT OF PVP ON CYCLODEXTRIN COMPLEXATION OF EFAVIRENZ FOR ENHANCING ITS SOLUBILITY AND DISSOLUTION
More informationFORMULATION DEVELOPMENT AND IN-VITRO CHARACTERIZATION OF BILAYER TABLETS OF AMOXICILLIN AND FAMOTIDINE
ISSN: 2395 1338 FORMULATION DEVELOPMENT AND IN-VITRO CHARACTERIZATION OF BILAYER TABLETS OF AMOXICILLIN AND FAMOTIDINE B. Venkateswara Reddy *, K. Navaneetha Department of Pharmaceutics, St.Paul s College
More informationFORMULATION, EVALUATION AND OPTIMIZATION OF SOLID DISPERSION OF GLIPIZIDE USING FACE CENTERED CENTRAL COMPOSITE DESIGN
Academic Sciences International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 0975-1491 Vol 3, Suppl 5, 2011 Research Article FORMULATION, EVALUATION AND OPTIMIZATION OF SOLID DISPERSION OF GLIPIZIDE
More informationInt. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN:
International Research Journal of Pharmaceutical and Applied Sciences (IRJPAS) Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2014; 4(1):47-51 Research Article FORMULATION AND EVALUATION
More informationTo study the effect that hydroxypropylcellulose (HPC) polymer molecular weight (MW) exerts on drug release rates and mechanism from matrix tablets.
PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-029-1 (Supersedes PTR 029) Page 1 of 7 Hydroxypropylcellulose in Modified Release Matrix Systems: Polymer Molecular Weight Controls
More informationFormulation and Evaluation
Chapter-5 Formulation and Evaluation 5.1 OBJECTIVE After successful taste masking and solubility enhancement of drugs in preliminary studies, by using Mannitol Solid Dispersion, next step includes the
More informationHydrodynamic Robustness of Hypromellose and Methylcellulose Based Modified Release Matrix Systems D. Tewari, R. K. Lewis, W. W. Harcum and T Dürig
PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-069-1 (Supersedes PTR-069) Page 1 of 8 Hydrodynamic Robustness of Hypromellose and Methylcellulose Based Modified Release Matrix Systems
More informationFormulation Development and In-Vitro Evaluation of Gastroretentive Floating tablets of Atenolol
Formulation Development and In-Vitro Evaluation of Gastroretentive Floating tablets of Atenolol K.Viveksarathi, K.Kannan*, S.Selvamuthu Kumar, R.Manavalan Department of Pharmacy, Faculty of Engineering
More information372 J App Pharm Vol. 6; Issue 4: ; October, 2014 Moazzem et al, 2014
372 J App Pharm Vol. 6; Issue 4: 372-379; October, 2014 Moazzem et al, 2014 Original Research Article EFFECT OF SUPERDISINTEGRATING AGENT ON THE RELEASE OF METFORMIN HCl FROM IMMEDIATE RELEASE TABLETS
More informationScholars Research Library
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2011, 3(1): 38-44 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationMuniyandy SARAVANAN,*,a Kalakonda SRI NATARAJ, a and Kettavarampalayam Swaminath GANESH b
978 Notes Chem. Pharm. Bull. 51(8) 978 983 (2003) Vol. 51, No. 8 Hydroxypropyl Methylcellulose Based Cephalexin Extended Release Tablets: Influence of Tablet Formulation, Hardness and Storage on in Vitro
More informationFeasibility of using natural gums for development of sustained release matrix tablet of itopride
Available online at wwwscholarsresearchlibrarycom Scholars Research Library Der Pharmacia Lettre, 215, 7 (3):114-123 (http://scholarsresearchlibrarycom/archivehtml) ISSN 975-571 USA CODEN: DPLEB4 Feasibility
More informationBiswajit Biswal IRJP 2 (7)
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN 2230 8407 Available online http://www.irjponline.com Research Article DESIGN DEVELOPMENT AND EVALUATION OF TRIMETAZIDINE DIHYDROCHLORIDE FLOATING BILAYER
More information5.1 STANDARD CURVES OF DRUGS USED
223 Glipizide and Glimepiride matrix tablets were prepared by using Aloe barbadensis miller leaves mucilage, Guar gum, Povidone and were evaluated. Similarly Glipizide and Glimepiride transdermal patches
More informationFormulation and In-vitro Evaluation of Chewable Tablets of Montelukast Sodium
Available online on www.ijddt.com International Journal of Drug Delivery Technology 214; (3); 98-13 Research Article ISSN: 97 441 Formulation and In-vitro Evaluation of Chewable Tablets of Montelukast
More informationResearch Article Formulation and In-Vitro Evaluation of Fast Disintegrating Rosiglitazone Sublingual Tablets
Research Article Formulation and In-Vitro Evaluation of Fast Disintegrating Rosiglitazone Sublingual Tablets Bhanja Satyabrata *, Hardel Danendra K and Sudhakar Muvvala Department of Pharmaceutics, Malla
More informationENHANCEMENT OF SOLUBILITY, DISSOLUTION RATE AND BIOAVAILABILITY OF RITONAVIR BY CYCLODEXTRINS AND SOLUTOL HS15 - A FACTORIAL STUDY
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article ENHANCEMENT OF SOLUBILITY, DISSOLUTION RATE AND BIOAVAILABILITY OF RITONAVIR BY CYCLODEXTRINS
More informationMODULATION OF GASTROINTESTINAL TRANSIT TIME OF SALBUTAMOL SULPHATE BY FLOATING APPROCHES
Pooja et al Journal of Drug Delivery & Therapeutics; 213, 3(3), 37-41 37 Available online at http://jddtonline.info RESEARCH ARTICLE MODULATION OF GASTROINTESTINAL TRANSIT TIME OF SALBUTAMOL SULPHATE BY
More informationCHAPTER 8 HYDROGEL PLUG FORMULATION AND EVAUATION
CHAPTER 8 HYDROGEL PLUG FORMULATION AND EVAUATION 8.1 Preparation of erodible tablet plug (Hydrogel Plug) Direct compression method was used to prepare the erodible tablet plug. The compositions of different
More informationJournal of Chemical and Pharmaceutical Research
Available on line www.jocpr.com Journal of Chemical and Pharmaceutical Research ISSN No: 0975-7384 CODEN(USA): JCPRC5 J. Chem. Pharm. Res., 2010, 2(4):993-998 Formulation and evaluation of Prednisolone
More informationEvaluation of Ethyl Cellulose as Microencapsulating Agent for Controlled Release of Glimepiride
Asian Journal of Chemistry Vol. 20, No. 8 (2008), 5924-5930 Evaluation of Ethyl Cellulose as Microencapsulating Agent for Controlled Release of Glimepiride K.P.R. CHOWDARY* and SRINIVAS PANGULURI University
More informationENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF NIMESULIDE BY CYCLODEXTRINS, POLOXAMER AND PVP
Int. J. Chem. Sci.: 9(2), 20, 637-646 ISSN 0972-768X www.sadgurupublications.com ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF NIMESULIDE BY CYCLODEXTRINS, POLOXAMER AND PVP K. P. R. CHOWDARY *, K.
More informationBiowaiver Study on Prednisolone Tablets 5 mg in Three Different Brands. Marketed in Sudan. Safaa Mohamed *, Tilal Elsaman
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2017, 9 [4]:8-114 [http://scholarsresearchlibrary.com/archive.html] ISSN 0975-5071 USA CODEN: DPLEB4
More informationAvailable online Research Article
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 26, 8(2):7-7 Research Article ISSN : 975-7384 CODEN(USA) : JCPRC5 Optimization of directly compressible mixtures of microcrystalline
More informationIn-Vitro Studies of Diclofenac Sodium Controlled-release from Biopolymeric Hydrophilic Matrices.
In-Vitro Studies of Diclofenac Sodium Controlled-release from Biopolymeric Hydrophilic Matrices. Silvina A. Bravo, Maria C. Lamas, Claudio J. Salomón Department of Pharmacy. Faculty of Biochemical and
More informationDevelopment And Evaluation Of Gastroretentive Floating Tablet Of Rosuvastatin
Development And Evaluation Of Gastroretentive Floating Tablet Of Rosuvastatin Amiya kumar Prusty, Archana P. Chand Institute of Pharmacy and Technology, salipur, Biju Patnaik University of technology,
More informationFormulation and evaluation of immediate release salbutamol sulphate
5 Formulation, optimization and evaluation of immediate release layer of salbutamol sulphate Salbutamol is moderately selective beta (2)-receptor agonist similar in structure to terbutaline and widely
More informationA STUDY ON SUITABILITY OF NIMESULIDE-BETACYCLODEXTRIN COMPLEX IN ORAL AND TOPICAL DOSAGE FORMS
International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 1, Suppl 1, Nov.-Dec. 2009 Research Article A STUDY ON SUITABILITY OF NIMESULIDE-BETACYCLODEXTRIN COMPLEX IN ORAL AND TOPICAL DOSAGE
More informationCONTENTS PAGE. Please note: Preface Matrix system Selection of METOLOSE grades Specifications
Hypromellose CONTENTS PAGE 2 Preface Matrix system Selection of METOLOSE grades Specifications Properties Powder Solution Application Related Patents 3 4-5 6 8 10 13 14 17 Please note: The information
More informationFormulation and In vitro Release Characterization of Metoprolol Succinate Extended Release Tablets
Sakthikumar et al: Formulation and In vitro Release Characterization of Metoprolol Succinate Extended Release Tablets 1537 International Journal of Pharmaceutical Sciences and Nanotechnology Volume 4 Issue
More informationJournal of Chemical and Pharmaceutical Research
Available on line www.jocpr.com Journal of Chemical and Pharmaceutical Research ISSN No: 0975-7384 CODEN(USA): JCPRC5 J. Chem. Pharm. Res., 2011, 3(3):348-352 Formulation and in vitro evaluation of modified
More informationA study on the effects of different surfactants on Ethylcellulose microspheres
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.1, No.4, pp 966-971, Oct-Dec 2009 A study on the effects of different surfactants on Ethylcellulose microspheres Lalduhsanga
More informationPREPARATION AND INVITRO EVALUATION OF RABEPRAZOLE SODIUM DELAYED RELEASE ENTERIC COATED TABLETS
Page1000 Indo American Journal of Pharmaceutical Research, 2014 ISSN NO: 2231-6876 Journal home page: http:///index.php/en/ INDO AMERICAN JOURNAL OF PHARMACEUTICAL RESEARCH PREPARATION AND INVITRO EVALUATION
More informationFormulation Development and Evaluation of Modified Release Tablet using a Fixed Dose Combination of Antidiabetic Agents
Research Article Formulation Development and Evaluation of Modified Release Tablet using a Fixed Dose Combination of Antidiabetic Agents Nishit Gohel 1*, D M Patel 2, Komal Patel 3, Jignasa Modi 4 1 School
More informationInternational Journal of Innovative Pharmaceutical Sciences and Research
International Journal of Innovative Pharmaceutical Sciences and Research www.ijipsr.com ENHANCEMENT OF SOLUBILITY OF RITONAVIR BY USING SOLID DISPERSION TECHNIQUE 1 K.Sai Saran*, 2 M.Srujan Kumar, 3 Dr.K.V.Subrahmanyam
More informationIn vitro In vivo correlation of sustained release capsules of Metoprolol
In vitro In vivo correlation of sustained release capsules of Metoprolol K.Kannan*, R.Manavalan, P.K.Karar Department of Pharmacy, Annamalai University, Annamalai Nagar-608002, TamilNadu, India. ABSTRACT
More information